Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05848427
What this trial is testing

The LUSZ COVID-19 Severity Index: A Prognostic and Predictive Score of Mortality for Hospitalized Patients With Covid-19

Who this might be right for
COVID-19
Lebanese University 1,000
Not applicableStudy completedNCT04334954
What this trial is testing

SARS-COV2 Pandemic Serosurvey and Blood Sampling

Who this might be right for
SARS-COV2 Virus
National Institute of Allergy and Infectious Diseases (NIAID) 11,363
Not applicableStudy completedNCT04723446
What this trial is testing

Efficacy of Mouthwashes in Reducing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Saliva

Who this might be right for
Covid19Coronavirus
Queen Mary University of London 54
Not applicableUnknownNCT04877496
What this trial is testing

Responses to COVID19 Vaccination in Patients With a Treatment History of Rituximab.

Who this might be right for
COVID19 VaccinationRituximabImmunosuppression
Insel Gruppe AG, University Hospital Bern 425
Not applicableStudy completedNCT06891170
What this trial is testing

B Cell Responses in COVID-19

Who this might be right for
COVID 19
Fondazione IRCCS Policlinico San Matteo di Pavia 4
Large-scale testing (Phase 3)Ended earlyNCT05531149
What this trial is testing

Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia

Who this might be right for
Respiratory InfectionPneumoniaCommunity-acquired Pneumonia+5 more
Biotest 107
Testing effectiveness (Phase 2)Study completedNCT05152849
What this trial is testing

Efficacy, Safety, Tolerability of AXA1125 in Fatigue After COVID-19 Infection

Who this might be right for
Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection
Axcella Health, Inc 41
Not applicableStudy completedNCT04425213
What this trial is testing

Obesity and Mortality of Critically Ill Patients With COVID-19

Who this might be right for
COVIDSevere Acute Respiratory SyndromeObesity+1 more
Central Hospital, Nancy, France 250
Not applicableStudy completedNCT06636760
What this trial is testing

Efficacy and Immunomodulator Impact of Herbal Combination on COVID-19 Patients Recovery

Who this might be right for
COVID 19
Universitas Indonesia 66
Large-scale testing (Phase 3)UnknownNCT04352933
What this trial is testing

PROLIFIC ChemoprophylaxisTrial (COVID-19)

Who this might be right for
COVID-19
Cambridge University Hospitals NHS Foundation Trust 1,000
Post-approval studies (Phase 4)UnknownNCT04350684
What this trial is testing

Umifenovir in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
Shahid Beheshti University of Medical Sciences 40
Not applicableStudy completedNCT05341635
What this trial is testing

FAst and SimplE COVID-19 Causing Virus SARS-CoV-2 Detection

Who this might be right for
COVID-19
University of Milano Bicocca 200
Testing effectiveness (Phase 2)Study completedNCT04808284
What this trial is testing

Neuromodulation in COVID-19 Patients

Who this might be right for
COVID-19
D'Or Institute for Research and Education 60
Not applicableActive Not RecruitingNCT06231238
What this trial is testing

Balance Acceptance and Commitment Therapy for Long COVID

Who this might be right for
Post-COVID-19 SyndromeLong COVID
King's College London 196
Testing effectiveness (Phase 2)Study completedNCT04481685
What this trial is testing

A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Covid19
University of Kansas Medical Center 20
Large-scale testing (Phase 3)Study completedNCT04425915
What this trial is testing

Efficacy of Convalescent Plasma Therapy in Patients With COVID-19

Who this might be right for
COVID
Institute of Liver and Biliary Sciences, India 400
Large-scale testing (Phase 3)UnknownNCT04460443
What this trial is testing

Sofosbuvir in Treatment of COVID 19

Who this might be right for
COVID
Tanta University 60
Not applicableStudy completedNCT04381338
What this trial is testing

Rehabilitation for People With COVID-19 in ICU

Who this might be right for
Corona Virus Disease 19 (COVID-19)COVIDAcute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)+1 more
University of Padova 96
Not applicableStudy completedNCT04441684
What this trial is testing

Seroprevalence of SARS-CoV-2 in Strasbourg University Hospital, Strasbourg, France (COVID-19)

Who this might be right for
SARS-CoV-2 Serological StatusSARS-CoV-2 Seroprevalence
University Hospital, Strasbourg, France 1,466
Not applicableStudy completedNCT04412278
What this trial is testing

Impact of COVID-19 Pandemic on Perceived Exercise Benefits and Barriers

Who this might be right for
COVIDIsolation, Social
Okan University 392
Next Page